Precision Medicine in Colorectal Cancer: Harnessing the Power of MRD Surveillance and Emerging Guidelines
FDA Approves Pimicotinib for TGCT Following Positive Phase 3 MANEUVER Trial Results
Joe Biden Says Prostate Cancer Is Slowing Him Down Ahead of Memoir Release
Preoperative Single-Fraction and Fractionated Stereotactic Radiotherapy Show Comparable Outcomes in Resectable Brain Metastases
We Live in Time: When Cancer Changes the Meaning of Time
Beyond EGFR Mutations: New Study Reveals Why Some Lung Cancer Cells Survive Osimertinib
Breast Cancer in Michelangelo’s Sistine Chapel? A 500-Year-Old Fresco Sparks a Modern Medical Debate
Kate Middleton Opens Up About Cancer Recovery: Why Healing Is Not Always Linear
The ESMO Preceptorship on Endocrine Tumours 2026: Lugano is scheduled for July 8–9, 2026, in Lugano, Switzerland. Co-chaired by Alfredo Berruti and Rocio Garcia-Carbonero, this intensive educational course is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endocrine neoplasms. The curriculum typically focuses on the latest standards of care, […]
ESMO Preceptorship on Breast Cancer 2026 will take place from 10 Jul 2026 to 11 Jul 2026 in Munich, Germany, under the leadership of Co-Chairs Nadia Harbeck (Munich, Germany) and Peter Schmid (United Kingdom). The program is designed to enable the interdisciplinary discussion and collaboration in the care of patients with breast cancer, to understand […]
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by the European Society for Medical Oncology (ESMO), the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez […]
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational […]
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 at 18:30 CEST. The session will examine the reliability of current HRD testing, the role of PARP inhibitors in maintenance therapy, and the emerging potential […]
The “Optimising Antibody–Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities 2026” webinar, organized by the European Society for Medical Oncology (ESMO), will take place on September 9, 2026, at 6:30 PM CEST (8:30 PM AMT). Part of the ESMO Therapeutic Landscapes series, the session will focus on recognising, preventing, and managing toxicities associated with […]
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 […]
The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich, Switzerland, from September 18–19, 2026. Chaired by Natalie Cook and Benedikt Westphalen, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases, from diagnosis to treatment, according to current […]
The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 29–30 September 2026 […]
The ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday, September 30, 2026, starting at 18:30 CEST. As uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens […]
The ESMO Guidelines: Real World Cases Webinar – Early Stage and Locally Advanced NSCLC 2026, organized by the European Society for Medical Oncology (ESMO), will take place on September 30, 2026, at 6:30 PM CEST (8:30 PM AMT). The webinar will review the latest evidence-based recommendations for early-stage and locally advanced non-small-cell lung cancer (NSCLC), […]
The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on treatment sequencing, the biology of metastatic breast cancer, targeted therapy safety and adverse-event management, and multidisciplinary approaches to improving […]
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as […]
The ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on October 7, 2026, at 6:30 PM CEST (8:30 PM AMT). This live educational webinar will examine how new concepts and therapeutic strategies are reshaping […]
The ESMO Congress Highlights Webinar: Gastrointestinal Cancers 2026, organized by the European Society for Medical Oncology (ESMO), will take place online on November 9, 2026, at 18:30 CET. The webinar is part of the ESMO Congress Highlights series, designed to review important research findings presented at the ESMO Congress 2026 and explore their potential implications […]
The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona, Spain, from November 11–12, 2026. This specialized educational program is co-chaired by Simon Ekman, Lizza Hendriks, and Natasha Leighl, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies […]
